Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial
Millions of members who had relied on medications like Wegovy, Zepbound, and Saxenda woke up to letters explaining that their weight loss medications would no longer be covered as of January 1, 2026
Vegan and Non-GMO
One reviewer described going from signup to medication delivery in under five days, which is among the fastest timelines in the telehealth GLP-1 space
This guide covers: How both medications work (same class, different molecules) Weight loss effectiveness: what the research shows Dosing schedules and administration differences Side effect comparison Cardiovascular and metabolic benefits Cost and insurance considerations Who might still consider Saxenda Making the transition from Saxenda to semaglutide Key Takeaways Both are GLP-1 receptor agonists working through the same fundamental mechanism to reduce appetite and enhance satiety Semaglutide produces roughly twice the weight loss (15% average) compared to liraglutide (5-8% average) Dosing convenience favors semaglutide: Weekly injection versus daily injection with Saxenda Side effects are similar since both work through GLP-1 pathways (primarily gastrointestinal) Saxenda is FDA-approved for weight loss
Administration Phentermine: Daily pill GLP-1: Weekly injection Some people prefer pills, while others like the convenience of once-weekly dosing
